142 related articles for article (PubMed ID: 28594934)
1. Effects of PPARα inhibition in head and neck paraganglioma cells.
Florio R; De Lellis L; di Giacomo V; Di Marcantonio MC; Cristiano L; Basile M; Verginelli F; Verzilli D; Ammazzalorso A; Prasad SC; Cataldi A; Sanna M; Cimini A; Mariani-Costantini R; Mincione G; Cama A
PLoS One; 2017; 12(6):e0178995. PubMed ID: 28594934
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of PPARα induces cell cycle arrest and apoptosis, and synergizes with glycolysis inhibition in kidney cancer cells.
Abu Aboud O; Wettersten HI; Weiss RH
PLoS One; 2013; 8(8):e71115. PubMed ID: 23951092
[TBL] [Abstract][Full Text] [Related]
3. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
[TBL] [Abstract][Full Text] [Related]
4. PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth.
Abu Aboud O; Donohoe D; Bultman S; Fitch M; Riiff T; Hellerstein M; Weiss RH
Am J Physiol Cell Physiol; 2015 Jun; 308(11):C890-8. PubMed ID: 25810260
[TBL] [Abstract][Full Text] [Related]
5. Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells.
Florio R; De Lellis L; Veschi S; Verginelli F; di Giacomo V; Gallorini M; Perconti S; Sanna M; Mariani-Costantini R; Natale A; Arduini A; Amoroso R; Cataldi A; Cama A
Sci Rep; 2018 Sep; 8(1):13610. PubMed ID: 30206358
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate down-regulates renal OCT2-mediated organic cation transport via PPARα-independent pathways.
Asavapanumas N; Kittayaruksakul S; Meetam P; Muanprasat C; Chatsudthipong V; Soodvilai S
Drug Metab Pharmacokinet; 2012; 27(5):513-9. PubMed ID: 22473497
[TBL] [Abstract][Full Text] [Related]
7. Opposing Effects of PPARα Agonism and Antagonism on Refractive Development and Form Deprivation Myopia in Guinea Pigs.
Pan M; Jiao S; Reinach PS; Yan J; Yang Y; Li Q; Srinivasalu N; Qu J; Zhou X
Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5803-5815. PubMed ID: 30521668
[TBL] [Abstract][Full Text] [Related]
8. PPARα induced NOS1 phosphorylation via PI3K/Akt in guinea pig antral mucous cells: NO-enhancement in Ca(2+)-regulated exocytosis.
Tanaka S; Hosogi S; Sawabe Y; Shimamoto C; Matsumura H; Inui T; Marunaka Y; Nakahari T
Biomed Res; 2016; 37(3):167-78. PubMed ID: 27356604
[TBL] [Abstract][Full Text] [Related]
9. PPARα agonists inhibit inflammatory activation of macrophages through upregulation of β-defensin 1.
Ann SJ; Chung JH; Park BH; Kim SH; Jang J; Park S; Kang SM; Lee SH
Atherosclerosis; 2015 Jun; 240(2):389-97. PubMed ID: 25881202
[TBL] [Abstract][Full Text] [Related]
10. PPARα autocrine regulation of Ca²⁺-regulated exocytosis in guinea pig antral mucous cells: NO and cGMP accumulation.
Tanaka S; Sugiyama N; Takahashi Y; Mantoku D; Sawabe Y; Kuwabara H; Nakano T; Shimamoto C; Matsumura H; Marunaka Y; Nakahari T
Am J Physiol Gastrointest Liver Physiol; 2014 Dec; 307(12):G1169-79. PubMed ID: 25342048
[TBL] [Abstract][Full Text] [Related]
11. PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway.
Wang W; Lin Q; Lin R; Zhang J; Ren F; Zhang J; Ji M; Li Y
Exp Cell Res; 2013 Jun; 319(10):1523-33. PubMed ID: 23603572
[TBL] [Abstract][Full Text] [Related]
12. Leptin induces hypertrophy through activating the peroxisome proliferator-activated receptor α pathway in cultured neonatal rat cardiomyocytes.
Hou N; Luo MS; Liu SM; Zhang HN; Xiao Q; Sun P; Zhang GS; Luo JD; Chen MS
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1087-95. PubMed ID: 20738325
[TBL] [Abstract][Full Text] [Related]
13. PPARalpha and PP2A are involved in the proapoptotic effect of conjugated linoleic acid on human hepatoma cell line SK-HEP-1.
Muzio G; Maggiora M; Oraldi M; Trombetta A; Canuto RA
Int J Cancer; 2007 Dec; 121(11):2395-401. PubMed ID: 17691108
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
[TBL] [Abstract][Full Text] [Related]
15. PPARalpha ligands cause lymphocyte depletion and cell cycle block and this is associated with augmented TRB3 and reduced Cyclin B1 expression.
Morse E; Selim E; Cunard R
Mol Immunol; 2009 Oct; 46(16):3454-61. PubMed ID: 19748123
[TBL] [Abstract][Full Text] [Related]
16. Fenofibrate suppresses melanogenesis in B16-F10 melanoma cells via activation of the p38 mitogen-activated protein kinase pathway.
Huang YC; Liu KC; Chiou YL; Yang CH; Chen TH; Li TT; Liu LL
Chem Biol Interact; 2013 Oct; 205(3):157-64. PubMed ID: 23872139
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor alpha is involved in cardiomyocyte differentiation of murine embryonic stem cells in vitro.
Ding L; Liang X; Zhu D; Lou Y
Cell Biol Int; 2007 Sep; 31(9):1002-9. PubMed ID: 17467307
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with proteasome inhibitors protects against oxidative injuries via PPARα-dependent and -independent pathways in ARPE-19 cells.
Cai J; Sun L; Lin B; Wu M; Qu J; Snider BJ; Wu S
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5967-74. PubMed ID: 22879419
[TBL] [Abstract][Full Text] [Related]
19. A novel PPAR alpha/gamma dual agonist inhibits cell growth and induces apoptosis in human glioblastoma T98G cells.
Liu DC; Zang CB; Liu HY; Possinger K; Fan SG; Elstner E
Acta Pharmacol Sin; 2004 Oct; 25(10):1312-9. PubMed ID: 15456533
[TBL] [Abstract][Full Text] [Related]
20. Time-dependence of cardiomyocyte differentiation disturbed by peroxisome proliferator-activated receptor alpha inhibitor GW6471 in murine embryonic stem cells in vitro.
Ding L; Liang XG; Lou YJ
Acta Pharmacol Sin; 2007 May; 28(5):634-42. PubMed ID: 17439719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
